Log in

Relevant bibliographies by topics / And Anticancer

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'And Anticancer'

Author: Grafiati

Published: 2 June 2025

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'And Anticancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "And Anticancer"

1

Ayyad, Rezk R., Ahmed M. Mansour, Ahmed M. Nejm, Yasser Abdel Allem Hassan, and Ahmed R. Ayyad. "An Overview of Antibiotics Used in Cancer Treatment and Drugs that Act as Antimicrotubules." Journal of Progress in Engineering and Physical Science 3, no. 2 (2024): 25–32. http://dx.doi.org/10.56397/jpeps.2024.06.04.

Full text

Abstract:

The caner in general is an abnormal growth with no causes and route of transportation in the body, which is the difficult of treatment or limited of its spread. One of the methods of treatment is the chemotherapeutic agents, we will overview on Antibiotics and Antimicrotubules act as Anticancer. The Anticancer Antibiotics are Bleomycin, Dactinomycin, Daunorubicin, Epirubicin, Plicamycin, Doxorubicin, Mitomycin. Antimicrotubules, mostly, they are naturally compounds which inhibit the microtubules which responsible for the cell division and proliferation of the cancer cell specifically as Colchi

APA, Harvard, Vancouver, ISO, and other styles

2

H Al-Ghamdi, Fuad. "Effect of anticancer electromagnetic spectrums on the cancer cell line growths." Journal of Medical Pharmaceutical and Allied Sciences 13, no. 3 (2024): 6603–7. http://dx.doi.org/10.55522/jmpas.v13i3.6511.

Full text

Abstract:

Electromagnetic frequencies (EMF) that are generated from different electronic devices can interact with biological systems including humans. Several theories described the effects of EMF on the growth of in vitro cancer cell lines and biological systems, which revealed that EMF could inhibit cancer cell growth or decrease viability depending on the field strength and frequency. Accordingly, in this study, we are targeting to assess the effect of the anticancer-extracted electromagnetic spectrums on the growth of two types of cell lines which are the breast cancer cell line MCF-7 and human emb

APA, Harvard, Vancouver, ISO, and other styles

3

Ammazzalorso, Alessandra, and Marialuigia Fantacuzzi. "Anticancer Inhibitors." Molecules 27, no. 14 (2022): 4650. http://dx.doi.org/10.3390/molecules27144650.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Dove, Alan. "Anticancer verotoxin." Nature Biotechnology 17, no. 8 (1999): 738. http://dx.doi.org/10.1038/11646.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Reese, David M. "Anticancer drugs." Nature 378, no. 6557 (1995): 532. http://dx.doi.org/10.1038/378532c0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Worland, PhD, Peter J., Gary S. Gray, PhD, Mark Rolfe, PhD, Karen Gray, PhD, and Jeffrey S. Ross, MD. "Anticancer Antibodies." American Journal of Clinical Pathology 119, no. 4 (2003): 472–85. http://dx.doi.org/10.1309/y6lp-c0lr-726l-9dx9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Ross, Jeffrey S., Karen Gray, Gary S. Gray, Peter J. Worland, and Mark Rolfe. "Anticancer Antibodies." American Journal of Clinical Pathology 119, no. 4 (2003): 472–85. http://dx.doi.org/10.1309/y6lpc0lr726l9dx9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

LeBrasseur, Nicole. "Anticancer lubrication." Journal of Cell Biology 156, no. 6 (2002): 940. http://dx.doi.org/10.1083/jcb1566rr1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

VanHook, A. M. "Anticancer Cocktails." Science Signaling 7, no. 347 (2014): ec284-ec284. http://dx.doi.org/10.1126/scisignal.aaa0425.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

ROUHI, MAUREEN. "ANTICANCER VACCINE." Chemical & Engineering News 75, no. 3 (1997): 8. http://dx.doi.org/10.1021/cen-v075n003.p008.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "And Anticancer"

1

Hudnott, Anna Ruth. "Bioreductive anticancer agents." Thesis, University of Exeter, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.302640.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Braña, García Irene. "Anticancer targeted agent combination." Doctoral thesis, Universitat Autònoma de Barcelona, 2017. http://hdl.handle.net/10803/457506.

Full text

Abstract:

Las toxicidades limitantes de dosis fuero una neutropenia febril grado 4 (en el brazo de docetaxel) y una neutropenia grado 3 en el brazo de gemcitabina. La combinación de carlumab no tuvo un impacto El cáncer es una enfermedad altamente frecuente y con alta mortalidad. El desarrollo de fármacos contra el cáncer se ha caracterizado por su ineficiencia, con una de las tasas de aprobación de fármacos más baja entre las diferentes especialidades médicas. El principal motivo de esta baja tasa de éxito es la falta de eficacia de los nuevos fármacos que entran al desarrollo clínico. Se han plantea

APA, Harvard, Vancouver, ISO, and other styles

3

Rijt, Sabine H. van. "Osmium arene anticancer complexes." Thesis, University of Warwick, 2010. http://wrap.warwick.ac.uk/3213/.

Full text

Abstract:

Drawbacks associated with anticancer chemotherapeutic cisplatin include tumour drug resistance, non-effectiveness against all tumours and lack of tumour-specificity resulting in severe side-effects (e.g. nausea, hair loss and kidney toxicity). The use of other metals such as transition metals rutheniumandosmium, may address the problems associated with platinum drugs and have received increased interest over the years. In this thesis the biological activity and aqueous solution chemistry of half-sandwichosmium (II) compounds of the type [(arene)OsII(X)(YZ)] n+ is explored. Chelating ligands co

APA, Harvard, Vancouver, ISO, and other styles

4

Pettersson, Hanna Ilse. "Quinolinequinones as anticancer agents." Thesis, University of Exeter, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249038.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Coverdale, James P. C. "Catalytic organometallic anticancer complexes." Thesis, University of Warwick, 2017. http://wrap.warwick.ac.uk/99039/.

Full text

Abstract:

Half-sandwich complexes of ruthenium, iridium, and more recently osmium, have shown promise as anticancer agents. Many of these ‘piano-stool’ complexes appear to target the redox balance in cells. Separately, similar complexes have been investigated for the catalysis of hydrogenation reactions, with many examples achieving high turnover frequencies and enantioselectivities. This thesis is concerned with achieving in cell catalysis to increase drug potency and generate selectivity for cancer cells. A series of eighteen Os(II) and Ir(III) complexes, of the type [M(ηx-arene)(diamine)] (Os-arene:

APA, Harvard, Vancouver, ISO, and other styles

6

May, Christopher. "Synthesis of anticancer compounds." Thesis, Imperial College London, 1987. http://hdl.handle.net/10044/1/47237.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

McGowan, Geraldine. "Platinum picoline anticancer complexes." Thesis, University of Edinburgh, 2005. http://hdl.handle.net/1842/11119.

Full text

Abstract:

The 2-picoline (2-methylpyridine) complex, <i>cis</i>-[PtCl<sub>2</sub>(NH<sub>3</sub>)(2-pic)] (AMD473), is promising new generation platinum antitumour agent currently in clinical trials and highly active cisplatin resistant cell-lines. The antitumour activity of <i>trans </i>platinum complexes has attracted renewed interest since it has been shown that some <i>trans</i> compounds, in particular those possessing planar amine ligands, are anticancer-active. Therefore, three <i>trans</i> isomers, <i>trans</i>-[PtCl<sub>2</sub>(NH<sub>3</sub>)(2-pic)] (1), <i>trans-</i>[PtCl<sub>2</sub>(NH<sub

APA, Harvard, Vancouver, ISO, and other styles

8

Liu, Zhe. "Organometallic iridium anticancer complexes." Thesis, University of Warwick, 2011. http://wrap.warwick.ac.uk/52292/.

Full text

Abstract:

Cisplatin has been used to treat various types of cancers for over 30 years, however, a number of serious side-effects of cisplatin have stimulated the quest for other metal-based anticancer agents. Iridium complexes are generally thought to be too inert to possess high reactivity, and therefore, there are only a few previous reports of the antitumour activity of iridium complexes. In this thesis a wide range of organometallic IrIII cyclopentadienyl complexes of the type [(η5-Cpx)Ir(XY)Cl]0/+ (where Cpx = pentamethylcyclopentadienyl (Cp*), tetramethyl(phenyl)cyclopentadienyl (Cpxph) or tetrame

APA, Harvard, Vancouver, ISO, and other styles

9

Arbaeen, Abrar Fawzi S. "Platinum anticancer drug shortages." Thesis, The University of Sydney, 2019. http://hdl.handle.net/2123/21128.

Full text

Abstract:

The platinum-based chemotherapy drugs cisplatin, carboplatin, and oxaliplatin remain, despite their long-term use, as integral components in the treatment of more than 25 different human cancers. As such, shortages in their supply can have serious health and societal impacts on both the outcome and welfare of patients and on the healthcare systems as a whole. As all three drugs are no longer under patent protection, they are supplied in Australia, the U.S. and the U.K. by between four and 17 different pharmaceutical companies, which reduces the risk of drug shortages. Determining the number an

APA, Harvard, Vancouver, ISO, and other styles

10

Sandler, Joel Stuart. "Anticancer compounds from marine invertebrates /." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 2005. http://wwwlib.umi.com/cr/ucsd/fullcit?p3247792.

Full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "And Anticancer"

1

Grimm, Stefan, ed. Anticancer Genes. Springer London, 2014. http://dx.doi.org/10.1007/978-1-4471-6458-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Ojima, Iwao, Gregory D. Vite, and Karl-Heinz Altmann, eds. Anticancer Agents. American Chemical Society, 2001. http://dx.doi.org/10.1021/bk-2001-0796.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Todd, Adam, Paul W. Groundwater, and Jason H. Gill. Anticancer Therapeutics. John Wiley & Sons, Ltd, 2018. http://dx.doi.org/10.1002/9781118696194.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Missailidis, Sotiris, ed. Anticancer Therapeutics. John Wiley & Sons, Ltd, 2008. http://dx.doi.org/10.1002/9780470697047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Sotiris, Missailidis, ed. Anticancer therapeutics. John Wiley & Sons, 2008.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Tuli, Hardeep Singh. Anticancer Spices. Jenny Stanford Publishing, 2024. http://dx.doi.org/10.1201/9781003534662.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Georg, Gunda I., Thomas T. Chen, Iwao Ojima, and Dolatrai M. Vyas, eds. Taxane Anticancer Agents. American Chemical Society, 1994. http://dx.doi.org/10.1021/bk-1995-0583.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Goldstein, Lori J., and Robert F. Ozols, eds. Anticancer Drug Resistance. Springer US, 1994. http://dx.doi.org/10.1007/978-1-4615-2632-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Reddy, L. Harivardhan, and Patrick Couvreur, eds. Macromolecular Anticancer Therapeutics. Springer New York, 2010. http://dx.doi.org/10.1007/978-1-4419-0507-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Károly, Lapis, Eckhardt S, and International Union Against Cancer, eds. Anticancer drug research. Akadémiai Kiadó, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "And Anticancer"

1

Schacter, Lee, Marcel Rozencweig, Claude Nicaise, Renzo Canetta, Susan Kelley, and Laurie Smaldone. "Anticancer Drugs." In Early Phase Drug Evaluation in Man. Macmillan Education UK, 1990. http://dx.doi.org/10.1007/978-1-349-10705-6_49.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Schwab, Matthias, Elke Schaeffeler, and Hiltrud Brauch. "Anticancer Drugs." In Metabolism of Drugs and Other Xenobiotics. Wiley-VCH Verlag GmbH & Co. KGaA, 2012. http://dx.doi.org/10.1002/9783527630905.ch13.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Saeidnia, Soodabeh. "Anticancer Antibiotics." In New Approaches to Natural Anticancer Drugs. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-14027-8_4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Saeidnia, Soodabeh. "Anticancer Terpenoids." In New Approaches to Natural Anticancer Drugs. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-14027-8_5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Isnard-Bagnis, Corinne, Vincent Launay-Vacher, Svetlana Karie, and Gilbert Deray. "Anticancer drugs." In Clinical Nephrotoxins. Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-84843-3_22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Ramon, Anne Laure, and Claude Malvy. "Anticancer Oligonucleotides." In Macromolecular Anticancer Therapeutics. Springer New York, 2009. http://dx.doi.org/10.1007/978-1-4419-0507-9_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Zhao, Le, Zengyi Shao, and Jacqueline V. Shanks. "Anticancer Drugs." In Industrial Biotechnology. Wiley-VCH Verlag GmbH & Co. KGaA, 2016. http://dx.doi.org/10.1002/9783527807833.ch8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

De Conno, F., and K. Foley. "Anticancer therapy." In Cancer Pain Relief. Springer Netherlands, 1995. http://dx.doi.org/10.1007/978-94-011-0099-1_16.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Jahanshahlu, Leila, and Nima Rezaei. "Anticancer Antibiotics." In Handbook of Cancer and Immunology. Springer Nature Switzerland, 2024. http://dx.doi.org/10.1007/978-3-030-80962-1_252-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Sibaud, Vincent, Robert Baran, Bianca Maria Piraccini, Mario E. Lacouture, and Caroline Robert. "Anticancer Therapies." In Baran & Dawber's Diseases of the Nails and their Management. John Wiley & Sons, Ltd, 2018. http://dx.doi.org/10.1002/9781119323396.ch17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "And Anticancer"

1

Dezfuli, Neda K., Andrés F. Flórez, Saray Gallo, David P. Rivas, and Sambeeta Das. "Peanut Shaped Microrobots for Anticancer Therapy." In 2024 International Conference on Manipulation, Automation and Robotics at Small Scales (MARSS). IEEE, 2024. http://dx.doi.org/10.1109/marss61851.2024.10612718.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Zaidi, Awais Raza, Abdul Majid, and Muhammad Bilal. "Anticancer Drug Response Prediction Using Deep Learning." In 2024 Horizons of Information Technology and Engineering (HITE). IEEE, 2024. https://doi.org/10.1109/hite63532.2024.10777247.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

"14th International Congress on Targeted Anticancer Therapies (TAT 2016)." In 14th International Congress on Targeted Anticancer Therapies (TAT 2016). Frontiers Media SA, 2016. http://dx.doi.org/10.3389/978-2-88919-879-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Turánek, Jaroslav, Michaela Škrabalová, and Pavlína Knötigová. "Antimicrobial and anticancer peptides." In XIth Conference Biologically Active Peptides. Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 2009. http://dx.doi.org/10.1135/css200911128.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Mangalagiu, Violeta, Dumitrela Diaconu, Costel Moldoveanu, et al. "Hybrid and chimeric nitrogen heterocycles with biological activity." In Scientific seminar with international participation "New frontiers in natural product chemistry". Institute of Chemistry, Republic of Moldova, 2023. http://dx.doi.org/10.19261/nfnpc.2023.ab01.

Full text

Abstract:

Nitrogen heterocycles, especially azine and azole derivatives, are highly valuable scaffolds in medicinal chemistry, being the core components of a large variety of drugs with variously biological activity such as antiplasmodial and antimalarial, antitubercular, antibacterial, antifungal, anticancer, analgesic, antidepressant, anxiolytics, antihypertensive, anticoagulants, diuretics, etc. As a result, obtaining of such entities continues to arouse a strong interest from academia and industry. As part of our ongoing research in the area of nitrogen heterocyclic derivatives, we present herein so

APA, Harvard, Vancouver, ISO, and other styles

6

Zbancioc, Gheorghita, Costel Moldoveanu, and Ionel I. Mangalagiu. "Syntheses of new benzoquinoline derivatives with anticancer activity." In Conferința științifică națională cu participare internațională "Integrare prin cercetare și inovare", dedicată Zilei Internaționale a Științei pentru Pace și Dezvoltare. Moldova State University, 2025. https://doi.org/10.59295/spd2024n.92.

Full text

Abstract:

This work synthesized various novel benzo[c]quinoline compounds, detailed their structural features, and examined their anticancer activity in vitro. First, the nitrogen atom in benzo[c]quinoline is quaternized, and the in situ-formed ylide is then subjected to a [3+2] dipolar cycloaddition reaction. A detailed investigation was conducted to determine how successful traditional thermal heating (TH) synthesis was in comparison to microwave (MW) and ultrasonic (US) irradiation. FTIR, HRMS, and NMR were the three spectral techniques that were used to prove the structure of all the obtained compou

APA, Harvard, Vancouver, ISO, and other styles

7

Chandrasekhar, H. Raghu, P. Vasanth Raj, J. Venkata Rao, and N. Udupa. "Anticancer activity of hypericum mysorense." In 2009 International Conference on Biomedical and Pharmaceutical Engineering (ICBPE). IEEE, 2009. http://dx.doi.org/10.1109/icbpe.2009.5384082.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Lowe, Henry Isaac Cloore, Ngeh J. Toyang, Charah Watson, and Joseph Bryant. "Abstract 1754: Cycloartane anticancer activity." In Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA. American Association for Cancer Research, 2014. http://dx.doi.org/10.1158/1538-7445.am2014-1754.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Ciorteanu, Roxana Elena, Monica Sardaru, Dumitrela Diaconu, Ionel Mangalagiu, and Ramona Danac. "Synthesis and anticancer properties of new indolizinic derivatives." In Scientific seminar with international participation "New frontiers in natural product chemistry". Institute of Chemistry, Republic of Moldova, 2023. http://dx.doi.org/10.19261/nfnpc.2023.ab25.

Full text

Abstract:

Natural compounds with indolizine scaffolds have demonstrated numerous biological activities and have found use in medical research laboratories. Thys, the unique indolizine scaffold became an important system for the development of new drug candidates in medicinal chemistry. [1,2] Several indolizines with excellent anticancer activity and tubulin polymerization inhibitory potency have been reported recently, and our group contributed also to the field. [1,3] The goal of this study was the design, synthesis and anticancer evaluation of several new derivatives with symmetrical or unsymmetrical

APA, Harvard, Vancouver, ISO, and other styles

10

Li, Jiao, Pamela Crowell, and Jake Yue Chen. "Construct anticancer drug-drug correlation network." In the 2009 ACM symposium. ACM Press, 2009. http://dx.doi.org/10.1145/1529282.1529444.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "And Anticancer"

1

Cheng, Yi-Qiang, Cheng Wang, Shane Wesener, and Viahwakanth Potharla. Engineer Novel Anticancer Bioagents. Defense Technical Information Center, 2010. http://dx.doi.org/10.21236/ada535365.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Seol, Dai-Wu. TRAIL-Based Anticancer Drug Development. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada407205.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Hammond, Scott M. MicroRNA Inhibitors as Anticancer Therapies. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada475785.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Peterson, Blake R. Anticancer Inhibitors of AR-Mediated Gene Expression. Defense Technical Information Center, 2006. http://dx.doi.org/10.21236/ada463403.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Howard, David, Peter Bach, Ernst Berndt, and Rena Conti. Pricing in the Market for Anticancer Drugs. National Bureau of Economic Research, 2015. http://dx.doi.org/10.3386/w20867.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Inoue, Takashi, and Mamoru Narukawa. Anti-tumor efficacy of anti-PD-1/PD-L1 antibodies in combination with other anticancer drugs in solid tumors: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.10.0004.

Full text

Abstract:

Review question / Objective: The aim of this systematic review is to compare the combination of PD-1/PD-L1 inhibitors plus other anticancer drugs and monotherapies of PD-1/PD-L1 inhibitors in terms of antitumor efficacy in the solid tumors to better inform clinical practice. To this end, the proposed systematic review will address the following question: Which is the best choice to enhance response rate in subjects with solid tumors, PD-1/PD-L1 inhibitors plus cytotoxic agents or PD-1/PD-L1 inhibitors plus other targeted anticancer drugs? Condition being studied: Cancer is the leading cause of

APA, Harvard, Vancouver, ISO, and other styles

7

Klein, Mark. Development of Novel p16INK4a Mimetics as Anticancer Therapy. Defense Technical Information Center, 2014. http://dx.doi.org/10.21236/ada615123.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Hu, Xiaoyi. Human Methionine Aminopeptidase 1 (MetAP1) as a New Anticancer Target. Defense Technical Information Center, 2005. http://dx.doi.org/10.21236/ada436150.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Zhang, Jian-Ting. Molecular Study of Interactions between P-Glycoprotein and Anticancer Drugs. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada300162.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Biswas, Kaustav, and Samuel J. Danishefsky. Synthesis of Epothilone Analogs: Toward the Development of Potent Anticancer Drugs. Defense Technical Information Center, 2002. http://dx.doi.org/10.21236/ada409475.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!